| Comparison of HR MAS MR spectroscopic profiles of breast cancer tissue with clinical parameters B Sitter, S Lundgren, TF Bathen, J Halgunset, HE Fjosne, IS Gribbestad NMR in Biomedicine: An International Journal Devoted to the Development and …, 2006 | 277 | 2006 |
| Spermine and citrate as metabolic biomarkers for assessing prostate cancer aggressiveness GF Giskeødegård, H Bertilsson, KM Selnæs, AJ Wright, TF Bathen, T Viset, ... PloS one 8 (4), e62375, 2013 | 205 | 2013 |
| Breast cancer quantitative proteome and proteogenomic landscape HJ Johansson, F Socciarelli, NM Vacanti, MH Haugen, Y Zhu, I Siavelis, ... Nature communications 10 (1), 1600, 2019 | 180 | 2019 |
| Dynamic contrast‐enhanced MRI texture analysis for pretreatment prediction of clinical and pathological response to neoadjuvant chemotherapy in patients with locally advanced … JR Teruel, MG Heldahl, PE Goa, M Pickles, S Lundgren, TF Bathen, ... NMR in Biomedicine 27 (8), 887-896, 2014 | 164 | 2014 |
| MR-determined metabolic phenotype of breast cancer in prediction of lymphatic spread, grade, and hormone status TF Bathen, LR Jensen, B Sitter, HE Fjösne, J Halgunset, DE Axelson, ... Breast cancer research and treatment 104, 181-189, 2007 | 162 | 2007 |
| Metabolic characterization of triple negative breast cancer MD Cao, S Lamichhane, S Lundgren, A Bofin, H Fjøsne, ... BMC cancer 14, 1-12, 2014 | 159 | 2014 |
| Quantification of metabolites in breast cancer patients with different clinical prognosis using HR MAS MR spectroscopy B Sitter, TF Bathen, TE Singstad, HE Fjøsne, S Lundgren, J Halgunset, ... NMR in Biomedicine: An International Journal Devoted to the Development and …, 2010 | 158 | 2010 |
| Multivariate modeling and prediction of breast cancer prognostic factors using MR metabolomics GF Giskeødegård, MT Grinde, B Sitter, DE Axelson, S Lundgren, ... Journal of proteome research 9 (2), 972-979, 2010 | 155 | 2010 |
| Predicting survival and early clinical response to primary chemotherapy for patients with locally advanced breast cancer using DCE‐MRI R Johansen, LR Jensen, J Rydland, PE Goa, KA Kvistad, TF Bathen, ... Journal of Magnetic Resonance Imaging: An Official Journal of the …, 2009 | 151 | 2009 |
| T2-weighted MRI-derived textural features reflect prostate cancer aggressiveness: preliminary results G Nketiah, M Elschot, E Kim, JR Teruel, TW Scheenen, TF Bathen, ... European radiology 27, 3050-3059, 2017 | 150 | 2017 |
| Merging transcriptomics and metabolomics-advances in breast cancer profiling E Borgan, B Sitter, OC Lingjærde, H Johnsen, S Lundgren, TF Bathen, ... BMC cancer 10, 1-14, 2010 | 131 | 2010 |
| HR MAS MR spectroscopy in metabolic characterization of cancer S Moestue, B Sitter, T Frost Bathen, MB Tessem, I Susann Gribbestad Current topics in medicinal chemistry 11 (1), 2-26, 2011 | 121 | 2011 |
| Magnetic resonance metabolomics of intact tissue: a biotechnological tool in cancer diagnostics and treatment evaluation TF Bathen, B Sitter, TE Sjøbakk, MB Tessem, IS Gribbestad Cancer Research 70 (17), 6692-6696, 2010 | 116 | 2010 |
| High-resolution magic angle spinning (HR MAS) MR spectroscopy in metabolic characterization of human cancer B Sitter, TF Bathen, MB Tessem, IS Gribbestad Progress in nuclear magnetic resonance spectroscopy 54 (3-4), 239-254, 2009 | 111 | 2009 |
| Cervical cancer tissue characterized by high-resolution magic angle spinning MR spectroscopy B Sitter, T Bathen, B Hagen, C Arentz, FE Skjeldestad, IS Gribbestad Magnetic Resonance Materials in Physics, Biology and Medicine 16, 174-181, 2004 | 107 | 2004 |
| Integrative clustering reveals a novel split in the luminal A subtype of breast cancer with impact on outcome MR Aure, V Vitelli, S Jernström, S Kumar, M Krohn, EU Due, TH Haukaas, ... Breast Cancer Research 19, 1-18, 2017 | 102 | 2017 |
| Metabolic markers in blood can separate prostate cancer from benign prostatic hyperplasia GF Giskeødegård, AF Hansen, H Bertilsson, SV Gonzalez, KA Kristiansen, ... British journal of cancer 113 (12), 1712-1719, 2015 | 102 | 2015 |
| Predicting long‐term survival and treatment response in breast cancer patients receiving neoadjuvant chemotherapy by MR metabolic profiling MD Cao, B Sitter, TF Bathen, A Bofin, PE Lønning, S Lundgren, ... NMR in Biomedicine 25 (2), 369-378, 2012 | 101 | 2012 |
| IDH1 R132H mutation generates a distinct phospholipid metabolite profile in glioma M Esmaeili, BC Hamans, AC Navis, R van Horssen, TF Bathen, ... Cancer research 74 (17), 4898-4907, 2014 | 100 | 2014 |
| Diffusion‐weighted and dynamic contrast‐enhanced MRI in evaluation of early treatment effects during neoadjuvant chemotherapy in breast cancer patients LR Jensen, B Garzon, MG Heldahl, TF Bathen, S Lundgren, IS Gribbestad Journal of Magnetic Resonance Imaging 34 (5), 1099-1109, 2011 | 97 | 2011 |
Guro GiskeødegårdNorwegian University of Science and Technology在 ntnu.no 的电子邮件经过验证
